Paul Cox
Public Communications Contact presso DYNAVAX TECHNOLOGIES CORPORATION
Profilo
Paul Cox is currently the VP-Investor Relations & Corporate Communications at Dynavax Technologies Corp.
He is also a Senior Associate at Stern Investor Relations, Inc. and the Head-Investor Relations & Communications at BioNTech US, Inc. Previously, he worked as the Director-Boston Chapter at the National Investor Relations Institute and as the Investor Relations Contact at SAGE Therapeutics, Inc. He was also the Vice President-Investor Relations at Voyager Therapeutics, Inc. from 2019 to 2020 and the Vice President-Investor Relations & Communications at Kymera Therapeutics, Inc. Mr. Cox completed his undergraduate degree at the University of Massachusetts and his graduate degree at Harvard Extension School.
Posizioni attive di Paul Cox
| Società | Posizione | Inizio |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Public Communications Contact | 01/01/2023 |
| NEON THERAPEUTICS, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2011 |
Precedenti posizioni note di Paul Cox
| Società | Posizione | Fine |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2020 |
| SAGE THERAPEUTICS, INC. | Investor Relations Contact | 01/03/2019 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Director/Board Member | - |
| KYMERA THERAPEUTICS, INC. | Investor Relations Contact | - |
Formazione di Paul Cox
| University of Massachusetts | Undergraduate Degree |
| Harvard Extension School | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| KYMERA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Paul Cox
